Spots Global Cancer Trial Database for Different Durations of Adjuvant Anastrozole Therapy After 2 to 3 Years Tamoxifen Therapy in Breast Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Different Durations of Adjuvant Anastrozole Therapy After 2 to 3 Years Tamoxifen Therapy in Breast Cancer
Official Title: A Prospective Randomised, Open, Multicentre, Phase III Study to Assess Different Durations of Anastrozole Therapy After 2 to 3 Years Tamoxifen as Adjuvant Therapy in Postmenopausal Women With Breast Cancer.
Study ID: NCT00301457
Conditions
Interventions
Study Description
Brief Summary: The purpose of this study is to determine whether 6 years adjuvant anastrozole will improve the disease free survival compared to 3 years adjuvant anastrozole in postmenopausal hormone sensitive breast cancer patients, subsequent to 2-3 years tamoxifen
Detailed Description:
Eligibility
Minimum Age: 45 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: No
Locations
Research Site, Alkmaar, , Netherlands
Research Site, Almelo, , Netherlands
Research Site, Almere, , Netherlands
Research Site, Amersfoort, , Netherlands
Research Site, Amstelveen, , Netherlands
Research Site, Amsterdam, , Netherlands
Research Site, Apeldoorn, , Netherlands
Research Site, Arnhem, , Netherlands
Research Site, Bergen Op Zoom, , Netherlands
Research Site, Beugen, , Netherlands
Research Site, Breda, , Netherlands
Research Site, Capelle Aan Den IJssel, , Netherlands
Research Site, Den Bosch, , Netherlands
Research Site, Den Haag, , Netherlands
Research Site, Deventer, , Netherlands
Research Site, Dirksland, , Netherlands
Research Site, Doetinchem, , Netherlands
Research Site, Dordrecht, , Netherlands
Research Site, Drachten, , Netherlands
Research Site, Ede, , Netherlands
Research Site, Eindhoven, , Netherlands
Research Site, Emmen, , Netherlands
Research Site, Enschede, , Netherlands
Research Site, Geldrop, , Netherlands
Research Site, Geleen, , Netherlands
Research Site, Goes, , Netherlands
Research Site, Gorinchem, , Netherlands
Research Site, Gouda, , Netherlands
Research Site, Haarlem, , Netherlands
Research Site, Hardenberg, , Netherlands
Research Site, Heerenveen, , Netherlands
Research Site, Heerlen, , Netherlands
Research Site, Hengelo, , Netherlands
Research Site, Hilversum, , Netherlands
Research Site, Hoofddorp, , Netherlands
Research Site, Hoogeveen, , Netherlands
Research Site, Hoorn, , Netherlands
Research Site, Leeuwarden, , Netherlands
Research Site, Leiden, , Netherlands
Research Site, Leidschendam, , Netherlands
Research Site, Maastricht, , Netherlands
Research Site, Nieuwegein, , Netherlands
Research Site, Nijmegen, , Netherlands
Research Site, Purmerend, , Netherlands
Research Site, Roermond, , Netherlands
Research Site, Roosendaal, , Netherlands
Research Site, Rotterdam, , Netherlands
Research Site, Schiedam, , Netherlands
Research Site, Sneek, , Netherlands
Research Site, Spijkenisse, , Netherlands
Research Site, Stadskanaal, , Netherlands
Research Site, Terneuzen, , Netherlands
Research Site, Tiel, , Netherlands
Research Site, Tilburg, , Netherlands
Research Site, Uden, , Netherlands
Research Site, Utrecht, , Netherlands
Research Site, Veldhoven, , Netherlands
Research Site, Venlo, , Netherlands
Research Site, Vlissingen, , Netherlands
Research Site, Winschoten, , Netherlands
Research Site, Winterswijk, , Netherlands
Research Site, Woerden, , Netherlands
Research Site, Zaandam, , Netherlands
Research Site, Zevenaar, , Netherlands
Research Site, Zoetermeer, , Netherlands
Research Site, Zutphen, , Netherlands
Research Site, Zwolle, , Netherlands
Contact Details
Name: AstraZeneca Netherlands Medical Director, MD
Affiliation: AstraZeneca
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
